Status:
COMPLETED
Platelet Activation Markers in Pediatric Cardiac Surgery
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Coronary Disease
Eligibility:
All Genders
Up to 7 years
Brief Summary
In this study the focus will be on correlating the levels of platelet activation markers (proteins that are released when blood cells are activated)to the duration of cardiopulmonary bypass, temperatu...
Detailed Description
This research is being done because we would like to learn more about platelet dysfunction in children undergoing cardiopulmonary bypass. It has been an established fact that cardiopulmonary bypass c...
Eligibility Criteria
Inclusion
- Patients scheduled to have surgery involving cardiopulmonary bypass for congenital cardiac abnormalities.
- Age: Newborn to 7 years
- Gender: male and female
Exclusion
- Emergency surgery
- Weight less than 3 kg
- Age greater than 7 years
- Patients with low platelet counts (\<100,000)
- Patients on medications that are known to interfere with platelet function such as prostacyclins, non-steroidal anti-inflammatory drugs, plavix.
- Patients whose parents not willing to give consent
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00450151
Start Date
February 1 2007
End Date
February 1 2009
Last Update
March 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NewYork-Presbyterian Hospital-Weill Cornell Medical College
New York, New York, United States, 10065